The invention relates to a method of treating tinnitus by administering an alpha2delta ligand such as, for example, a compound of Formula ##STR1##

and pharmaceutically acceptable salts thereof, wherein R₁ is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.